Delivery Order SPE2DB20D3303-SPE2DB25FA3UM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $7,625.80. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery order is scheduled for completion by August 5, 2025, with...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $22,877.40 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery location is...
- The Defense Logistics Agency awarded a $10,016.78 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed price contract, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $2,504.70 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order was executed without a set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with a ceiling value of $6,706.07. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 prime vendor agreement through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections, valued at $5,504.59. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 28, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,814.18 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract issued under a...
- The Defense Logistics Agency awarded a delivery order valued at $11,924.08 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injections on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed price contract, awarded without set-aside designation through competitive procurement, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,850.21 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors. This firm fixed price contract, with a completion date of September 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. No set-aside...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3UMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections, with a ceiling value of $1,906.45. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The ultimate completion date is set for September 18, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply mission to support federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of medications across multiple therapeutic domains for military and veteran healthcare systems. The award of this specific order for Zepbound, a diabetes medication, reflects the contractor's continued role in supplying specialty pharmaceutical products to meet federal medical procurement requirements through the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/17/25 |